Currently receiving an from analysts at Wolfe Research , with a price target of $7.
Searching for biotech stocks under $10 reveals several companies with strong analyst backing and significant upcoming catalysts. As of late 2025 and early 2026, the following stocks are frequently highlighted by financial experts for their growth potential: Top Rated Biotech Stocks Under $10 :
Recent Phase 1b study results for its Crohn's disease treatment showed a favorable safety profile with no serious adverse events. : best biotech stocks to buy under $10
: Biotech stocks, particularly those under $10, are highly volatile and carry significant risk due to the clinical trial process. Experts like Warren Buffett often avoid the sector because there is no way to fully de-risk clinical trial outcomes.
It maintains significant institutional interest, with roughly 31 hedge fund holders reported. : Currently receiving an from analysts at Wolfe Research
The company recently expanded its pipeline by acquiring DMX-200 for kidney disease.
AI responses may include mistakes. For financial advice, consult a professional. Learn more : : Biotech stocks, particularly those under $10,
While reporting a net loss in mid-2025, it reaffirmed revenue growth guidance of 15–22%. : Trading around $8.05 as of April 2026.